BioCentury
ARTICLE | Clinical News

Atragen liposomal formulation of all-trans retinoic acid: phase II trial

July 27, 1998 7:00 AM UTC

Aronex Pharmaceuticals Inc. (ARNX), The Woodlands, Texas Product: Atragen liposomal formulation of all-trans retinoic acid Indication: Treat acute promyelocytic leukemia Status: ARNX completed enroll...